Dafna-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
83
Total Value
352661806
Accession Number
0001389933-25-000002
Form Type
13F-HR
Manager Name
Dafna-Capital-Management
Data Enrichment
94% identified
78 identified5 unidentified

Holdings

83 positions
Manager:
Search and click to pin securities to the top
Autolus Therapeutics plc
Shares:586.7K
Value:$909.3K
Sage Therapeutics, Inc.
Shares:108.2K
Value:$860.2K
Korro Bio, Inc.
Shares:47.1K
Value:$819.8K
Century Therapeutics, Inc.
Shares:1.7M
Value:$811.2K
Larimar Therapeutics, Inc.
Shares:371.4K
Value:$798.6K
M8001Q126
Shares:291.3K
Value:$789.4K
Taysha Gene Therapies, Inc.
Shares:522.5K
Value:$726.3K
BICYCLE THERAPEUTICS PLC
Shares:80.8K
Value:$686.0K
Neurogene Inc.
Shares:51.5K
Value:$603.1K
Cardiff Oncology, Inc.
Shares:150.0K
Value:$471.0K
Erasca, Inc.
Shares:340.0K
Value:$465.8K
InflaRx N.V.
Shares:450.0K
Value:$459.0K
Adicet Bio, Inc.
Shares:600.0K
Value:$453.0K
Aquestive Therapeutics, Inc.
Shares:142.0K
Value:$411.8K
COMPUGEN LTD
Shares:272.4K
Value:$397.7K
ADC Therapeutics SA
Shares:224.1K
Value:$316.0K
SUTRO BIOPHARMA, INC.
Shares:437.1K
Value:$284.4K
Aprea Therapeutics, Inc.
Shares:137.2K
Value:$279.8K
BiomX Inc.
Shares:401.1K
Value:$222.9K
64157F103
Shares:38.0K
Value:$221.9K